V020-4625 Screening compound: N-[4-(2-oxo-3-{[4-(trifluoromethyl)phenyl]methyl}-1,3-diazinan-1-yl)phenyl]-4-(trifluoromethyl)benzamide

V020-4625 Screening compound: N-[4-(2-oxo-3-{[4-(trifluoromethyl)phenyl]methyl}-1,3-diazinan-1-yl)phenyl]-4-(trifluoromethyl)benzamide
V020-4625 Screening compound: N-[4-(2-oxo-3-{[4-(trifluoromethyl)phenyl]methyl}-1,3-diazinan-1-yl)phenyl]-4-(trifluoromethyl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V020-4625
N-[4-(2-oxo-3-{[4-(trifluoromethyl)phenyl]methyl}-1,3-diazinan-1-yl)phenyl]-4-(trifluoromethyl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V020-4625

Molecular Formula

C26H21F6N3O2 (C26 H21 F6 N3 O2)

Compound Name

N-[4-(2-oxo-3-{[4-(trifluoromethyl)phenyl]methyl}-1,3-diazinan-1-yl)phenyl]-4-(trifluoromethyl)benzamide

IUPAC name

N-[4-(2-oxo-3-{[4-(trifluoromethyl)phenyl]methyl}-13-diazinan-1-yl)phenyl]-4-(trifluoromethyl)benzamide

SMILES

O=C(c1ccc(C(F)(F)F)cc1)Nc(cc1)ccc1N(CCCN1Cc2ccc(C(F)(F)F)cc2)C1=O

InChI

InChI=1S/C26H21F6N3O2/c27-25(28,29)19-6-2-17(3-7-19)16-34-14-1-15-35(24(34)37)22-12-10-21(11-13-22)33-23(36)18-4-8-20(9-5-18)26(30,31)32/h2-13H,1,14-16H2,(H,33,36)

InChI Key

OBSKGCCSDCRXFW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19897247

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

521.46

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.993

Distribution Coefficient, logD

5.993

Water Solubility, LogSw

-5.99

Polar Surface Area

42.888

Acid Dissociation Constant (pKa)

10.90

Base Dissociation Constant (pKb)

0.32

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.10

V020-4625 in Drug Discovery

Included in Screening Libraries

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with V020-4625 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V020-4625?
Check Price and Availability of V020-4625, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V020-4625 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V020-4625
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V020-4625
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V020-4625 available by request